A new study describes how a specific nuclear pore component is critical for the survival of circulating T cells. The findings identify a new node of T cell receptor signaling and could pave the way ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Neuvivo, a late-clinical stage biopharmaceutical company, today announced promising results from two groundbreaking publications on its investigational ...
Stakeholders ask for flexibility, more examples in FDA guidance on overall survival in cancer trials
Stakeholders asked the US Food and Drug Administration for more examples in comments on a recently issued guidance on the use of overall survival as an endpoint in oncology drug clinical trials. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results